CXCL13



CXCL13

V1VV1L2LL2E3EE3V4VV4Y5YY5Y6YY6T7TT7S8SS8L9LL9R10RR10C11CC11R12RR12C13CC13V14VV14Q15QQ15E16EE16S17SS17S18SS18V19VV19F20FF20I21II21P22PP22R23RR23R24RR24F25FF25I26II26D27DD27R28RR28I29II29Q30QQ30I31II31L32LL32P33PP33R34RR34G35GG35N36NN36G37GG37C38CC38P39PP39R40RR40K41KK41E42EE42I43II43I44II44V45VV45W46WW46K47KK47... and 40 more residue(s)...... and 40 more residue(s)

SMILES None
InChIKey None
Sequence VLEVYYTSLRCRCVQESSVFIPRRFIDRIQILPRGNGCPRKEIIVWKKNKSIVCVDPQAEWIQRMMEVLRKRSSSTLPVPVFKRKIP

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

CXCL13

V1VV1L2LL2E3EE3V4VV4Y5YY5Y6YY6T7TT7S8SS8L9LL9R10RR10C11CC11R12RR12C13CC13V14VV14Q15QQ15E16EE16S17SS17S18SS18V19VV19F20FF20I21II21P22PP22R23RR23R24RR24F25FF25I26II26D27DD27R28RR28I29II29Q30QQ30I31II31L32LL32P33PP33R34RR34G35GG35N36NN36G37GG37C38CC38P39PP39R40RR40K41KK41E42EE42I43II43I44II44V45VV45W46WW46K47KK47... and 40 more residue(s)...... and 40 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.